Early research (Phase 1)Looking for participantsNCT06608355
What this trial is testing
The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease
Who this might be right for
Early-onset Parkinson's Disease
iRegene Therapeutics Co., Ltd. 6